About 2 300 reports

III. MONOCLONAL ANTIBODY INDUSTRY ASSESSMENTS

  • Monoclonal Antibody
  • China
  • Biologics Sales
  • Industrial Production

The Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2020 report provides a detailed understanding and analysis of how and why companies enter monoclonal antibody partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors...

  • Monoclonal Antibody
  • World

The Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2014-2020 report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer monoclonal antibody partnering deals Most active companies...

  • Monoclonal Antibody
  • World

Global Monoclonal Antibodies Market 2021-2025 The analyst has been monitoring the monoclonal antibodies market and it is poised to grow by $ 63.41 bn during 2021-2025 progressing at a CAGR of 8% during the forecast period. Our report on monoclonal antibodies market provides a holistic analysis, market size and forecast,...

  • Monoclonal Antibody
  • World

Cancer Monoclonal Antibodies Market Report Overview Cancer Monoclonal Antibodies market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Cancer Monoclonal Antibodies market types and applications. It is a focused study on Cancer Monoclonal...

  • Monoclonal Antibody
  • World
  • APAC
  • Health Provider Density

Monoclonal Antibody Therapeutics Market Report Overview Monoclonal Antibody Therapeutics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Monoclonal Antibody Therapeutics market types and applications. It is a focused study on Monoclonal...

  • Therapy
  • Monoclonal Antibody
  • World
  • APAC
  • Health Provider Density

Major players in the arthritis monoclonal antibodies market are Johnson & Johnson, Roche, Novartis, Pfizer Inc, AbbVie Inc., Amgen Inc., Genentech, GSK, AstraZeneca PLC, and Mylan N.V. The global arthritis monoclonal antibodies market is expected to decline from $46.48 billion in 2019 to $45.18 billion in 2020 at a compound annual growth...

  • Monoclonal Antibody
  • Arthritis
  • World
  • Biologics Sales

Major players in the cancer monoclonal antibodies market are Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Genmab AS, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Merck & Co., and Spectrum Pharmaceuticals. The global cancer monoclonal antibodies market is expected to decline from $48.36 billion...

  • Monoclonal Antibody
  • World
  • United States
  • Cancer Incidence
  • Cancer Mortality

Major players in the conjugated monoclonal antibodies market are Pfizer Inc., F. Hoffmann-LA, Bristol -Myers Squibb, Merck & Co. Inc., Immunomedics Inc., Takeda Pharmaceuticals Industries Ltd., Daiichi Sankyo Company Limited, Actinium Pharmaceutical, Nordic Nanovector Inc. and Spectrum Pharmaceuticals Inc. The global conjugated monoclonal...

  • Monoclonal Antibody
  • Biopharmaceutical
  • World
  • United States

Major players in the biosimilar monoclonal antibodies market are Pfizer, Novartis, Allergan, Coherus BioSciences, Biocon, Amgen, Boehringer Ingelheim, Celltrion, BioXpress Therapeutics, and Intas Pharmaceuticals Limited. The global biosimilar monoclonal antibodies market is expected to decline from $3.21 billion in 2019 to $3.04 billion...

  • Biopharmaceutical
  • Monoclonal Antibody
  • United States
  • World
  • Biosimilar Approvals
  • Chronic Disease Prevalence

Major players in the breast cancer monoclonal antibodies (mAbs) market are Amgen, Mylan, Merck, Novartis, GlaxoSmithKline, Daiichi Sankyo, Biocad, Boehringer Ingelheim, Bristol-Myers Squibb, and Array BioPharma. The global breast cancer monoclonal antibodies market is expected to decline from $13.57 billion in 2019 to $12.60 billion...

  • Breast Cancer
  • Monoclonal Antibody
  • World
  • Cancer Mortality
  • Oncology Drug Sales

Monoclonal Antibodies (MAbS) Global Market Report 2020-30: Covid 19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global monoclonal antibodies (mabs) market as it emerges from the Covid 19 shut down. Description: Where is the largest...

  • Monoclonal Antibody
  • World

Abstract: - Global Monoclonal Antibodies Market to Reach $142.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Monoclonal Antibodies estimated at US$100.1 Billion in the year 2020, is projected to reach a revised size of US$142.2 Billion by 2027, growing at a CAGR of 5.1% over the analysis period...

  • Monoclonal Antibody
  • World
  • China
  • United States

The global cancer monoclonal antibodies market is currently witnessing strong growth. A cancer monoclonal antibody refers to a laboratory-generated molecule that is engineered to mimic the immune system’s attack on cancer cells. It can bind to antigens present on the surface of cancer cells and flag them to trigger...

  • Monoclonal Antibody
  • World

Global monoclonal antibody market can be presented as follows: 1. Monoclonal antibody drug market booms and is highly concentrated with the approvals for such drugs. Monoclonal antibody drugs have been maturing from a research target to an improved technology, from clinical research to commercialization over the...

  • Monoclonal Antibody
  • China
  • World
  • Number Of Enterprises
  • Drug Approval

Global Biosimilar Monoclonal Antibodies (mAbs) Market 2020-2024 The analyst has been monitoring the biosimilar monoclonal antibodies (mAbs) market and it is poised to grow by $ 8.65 bn during 2020-2024 progressing at a CAGR of 30% during the forecast period. Our reports on biosimilar monoclonal antibodies (mAbs) market...

  • Monoclonal Antibody
  • Biosimilar
  • World
  • Chronic Disease Prevalence

" Global Cancer Monoclonal Antibodies Market &Clinical Trial Insight 2024" Report Highlights: • Significance for Monoclonal Antibodies for Cancer Treatment • Global Cancer Monoclonal Antibodies Market Overview • Global Cancer Monoclonal Antibodies Pipeline by Phase & Indication • Global Cancer Monoclonal...

  • Monoclonal Antibody
  • World

MONOCLONAL ANTIBODIES

  • Biopharmaceutical
  • Monoclonal Antibody
  • Infectious Disease
  • Vaccine
  • Protein Therapy
  • Biotech Vaccine
  • APAC
  • Indiana
  • Health Expenditure
  • Drug Approval

Global Anti-CD20 Monoclonal Antibodies (mABs) Market: About this market This anti-CD20 monoclonal antibodies (mABs) market analysis considers sales from oncology, neurology, and immunology. Our analysis also considers the sales of anti-CD20 monoclonal antibodies (mABs) in Asia, Europe, North America, and ROW. In 2018,...

  • Monoclonal Antibody
  • World

III. MONOCLONAL ANTIBODY INDUSTRY ASSESSMENTS

  • Monoclonal Antibody
  • China
  • Biologics Sales
  • Employment Costs

## MONOCLONAL ANTIBODIES

  • Monoclonal Antibody
  • United States
  • Canada
  • APAC
  • Europe
  • Biosimilar Approvals
  • Cancer Incidence

Monoclonal Antibody Imports

  • Monoclonal Antibody
  • Therapy
  • Cardiovascular Disease
  • Oncology
  • China
  • World
  • Biologics Sales
  • Labour Force

## Monoclonal Antibodies

  • Public Health
  • Monoclonal Antibody
  • Immunodiagnostics
  • Molecular Diagnostics
  • North America
  • Hospital Revenue
  • Diagnostic Revenue

## Monoclonal Antibodies

  • Public Health
  • Monoclonal Antibody
  • Immunodiagnostics
  • Molecular Diagnostics
  • APAC
  • Hospital Revenue
  • Diagnostic Revenue

## Monoclonal Antibodies

  • Public Health
  • Monoclonal Antibody
  • Immunodiagnostics
  • Molecular Diagnostics
  • Europe
  • Hospital Revenue
  • Diagnostic Revenue

Report Scope: The global immunotherapy market can be segmented into the following types: checkpoint inhibitors, monoclonal antibodies, interferons and interleukins. This report does not include other immunotherapies such as vaccines and hormones. The scope of the report includes an overview of the global market and...

  • Immunotherapy
  • Monoclonal Antibody
  • World

## Types of Monoclonal Antibodies

  • Monoclonal Antibody
  • World
  • Health Expenditure
  • Cancer Incidence

## Monoclonal Antibodies

  • Public Health
  • Monoclonal Antibody
  • Infectious Disease
  • Molecular Diagnostics
  • Research And Development
  • APAC
  • World
  • Chronic Disease Prevalence
  • Gross Domestic Product

Abstract: - Global Immunosuppressants Market to Reach $44.1 Billion by 2027 - Amid the COVID-19 crisis, the global market for Immunosuppressants estimated at US$18.2 Billion in the year 2020, is projected to reach a revised size of US$44.1 Billion by 2027, growing at a CAGR of 13.5% over the analysis period 2020-2027....

  • Monoclonal Antibody
  • Transplantation
  • World
  • China
  • United States

Abstract: - Global Custom Antibody Market to Reach $552.1 Million by 2027 - Amid the COVID-19 crisis, the global market for Custom Antibody estimated at US$330.3 Million in the year 2020, is projected to reach a revised size of US$552.1 Million by 2027, growing at a CAGR of 7.6% over the analysis period 2020-2027....

  • Monoclonal Antibody
  • Polyclonal Antibody
  • World
  • China
  • United States